Additional file 1 of Prolonged infusion of remimazolam in surgical and medical intensive care unit patients: a pilot pharmacokinetic study

Figshare 2026 Open access

Read full text
Authors: Yuji Suzuki, Matsuyuki Doi, Aoki, Yoshitaka, Hiromi Kato, Kensuke Kobayashi, Soichiro Mimuro, Takashi Mochizuki, Takahiro Yamada, Motoyasu Miura, Shinya Uchida, Yoshiki Nakajima
DOI: 10.6084/m9.figshare.31097235
Cited by: 0

Abstract

Supplementary Material 1. Supplementary Figure S1. Plasma concentrations of remimazolam and its metabolite CNS 7054 in the medical ICU group. a Plasma remimazolam concentrations during continuous infusion. b Plasma remimazolam concentrations after termination of infusion. c Plasma CNS 7054 concentrations during remimazolam infusion. d Plasma CNS 7054 concentrations after termination of infusion. Filled circles represent remimazolam concentrations; open circles represent CNS 7054 concentrations for each individual case. Light-tone filled and open triangles represent the remimazolam and CNS 7054 concentrations of B-05, while light-tone filled and open squares represent the remimazolam and CNS 7054 concentrations of B-07

Fields of Study & Subjects

Anesthesia and Sedative Agents Intensive Care Unit Cognitive Disorders Antibiotics Pharmacokinetics and Efficacy

Publication details

Journal / source
Figshare
Publication date
1 January 2026